Literature DB >> 18427908

Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion.

Michihide Tokuhira1, Atsushi Iizuka2, Reiko Watanabe2, Naoya Sekiguchi3, Norihide Sato2, Chen-Kang Chien2, Yasunobu Sekiguchi2, Tomoe Nemoto2, Kyoko Hanzawa2, Jun-Ichi Tamaru4, Shinji Itoyama4, Hiroshi Suzuki5, Tsutomu Takeuchi3, Shigehisa Mori2, Masahiro Kizaki2.   

Abstract

We here report the case of a young Japanese woman diagnosed with chronic active Epstein-Barr virus (EBV) infection. Intensive therapy with the CHOP regimen was partially able to control virus expansion, but various central nervous system symptoms appeared and gradually progressed. EBV-encoded RNA, detected using in situ hybridization, disclosed the presence of EBV in liver and bone marrow tissue, and real-time PCR revealed the presence of EBV in the cerebrospinal fluid (CSF) and serum. CD3+CD4+CD8-CD56- T-cell expansion in the peripheral blood (PB) and CSF was also observed. Atrophic brain changes were progressive, and the patient died of central nervous system disturbance and pulmonary hemorrhage a year after diagnosis. Autopsy revealed that EBV-infected T lymphocytes with a phenotype similar to those seen in PB and CSF had infiltrated multiple organs: the lymph nodes, bone marrow, endocardium, pericardium, myocardium, spleen, liver, and spinal cord. There have been few previous reports of severe degenerative changes in the myocardium, liver, and spinal cord in patients with EBV infection. Although EBV occasionally infiltrates the central nervous system and brain, atrophic changes mediated by EBV are rare. The autopsy results of this case suggest the possibility of EBV-mediated, severe degenerative changes in multiple organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427908     DOI: 10.1007/s12185-008-0069-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  30 in total

Review 1.  Epstein-Barr virus-recent advances.

Authors:  Karen F Macsween; Dorothy H Crawford
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

2.  Chronic, symptomatic Epstein-Barr virus infections.

Authors:  A B Rickinson
Journal:  Immunol Today       Date:  1986-01

Review 3.  Epstein-Barr virus--associated diseases in humans.

Authors:  K Kawa
Journal:  Int J Hematol       Date:  2000-02       Impact factor: 2.490

Review 4.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

5.  Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2.

Authors:  K Kawa-Ha; E Franco; S Doi; K Yumura; S Ishihara; A Tawa; H Yabuuchi
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

6.  Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease.

Authors:  M Koyama; Y Takeshita; A Sakata; A Sawada; M Yasui; T Okamura; M Inoue; K Kawa
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

7.  Relapsing acute disseminated encephalomyelitis associated with chronic Epstein-Barr virus infection: MRI findings.

Authors:  H Shoji; T Kusuhara; Y Honda; H Hino; K Kojima; T Abe; M Watanabe
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.

Authors:  H Kikuta; Y Taguchi; K Tomizawa; K Kojima; N Kawamura; A Ishizaka; Y Sakiyama; S Matsumoto; S Imai; T Kinoshita
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

9.  Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus.

Authors:  I Anagnostopoulos; M Hummel; C Kreschel; H Stein
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

10.  NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype.

Authors:  Robert P Hasserjian; Nancy Lee Harris
Journal:  Am J Clin Pathol       Date:  2007-06       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.